← Back to Dashboard
AI-Driven Chemical Innovation

Pyrimidine

Origin Data Source OpenAlex
Analysis Computed Jul 2, 2026
AI Synthesis & Market Narrative
AI is accelerating molecular diversification and optimization in drug discovery, targeting complex pathways. Concurrently, pyrimidine derivatives are foundational in developing advanced nanoprobes for critical environmental and food safety detection.
Correlated Linguistic Patterns
["AI-driven molecular diversification" "ligand-based optimization" "silver nanocluster-based nanoprobe" "pyrimidine derivative"]
Driving Media Context
Plos.org • Jun 30, 2026

AI-driven molecular diversification and ligand-based optimization of macitentan derivatives targeting VEGFR1 and endothelin signaling pathways

Preeclampsia is a hypertensive disorder of pregnancy marked by angiogenic imbalance and endothelial dysfunction, driven largely by over expression of soluble...
Plos.org • Jun 29, 2026

Systematic design of auxotrophic strains and media conditions to probe metabolic functions in E. coli

Author summary Understanding gene function remains one of the central challenges in microbiology. Roughly 35% of E. coli genes have no confirmed metabolic ro...
Royal Society of Chemistry • Jun 28, 2026

Silver nanocluster-based nanoprobe for thiram determination in food and environment

Anal. Methods, 2026, Accepted ManuscriptDOI: 10.1039/D6AY00954A, CommunicationHui Dong, Xin-Ru Sun, Jing Zhu, Wei Wang, Zhong-Xia WangA novel silver nanoclus...
Plos.org • Jun 25, 2026

Severity-dependent metabolic rewiring in COVID-19 based on untargeted metabolomic profiling of patient plasma

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a major global health challenge, cha...
Nature.com • Jun 18, 2026

Methane storage using metal–dipyrazolate frameworks

Reversible phase transformations enable flexible metal–bipyrazolate frameworks to offer high deliverable methane capacities, high stability and recyclability...
GlobeNewswire • Jun 18, 2026

F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis

MANCHESTER, United Kingdom and OSAKA, Japan, June 18, 2026 (GLOBE NEWSWIRE) -- F2G Ltd and Shionogi & Co., Ltd (Head Office: Osaka, Japan; Chief Executive Of...
PRNewswire • Jun 17, 2026

UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)

Data indicate that KYGEVVI therapy improved survival and functional outcomes in people with TK2d.1 Additional data from the largest pool of information on TK...
Associated Press • Jun 17, 2026

UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)

Data indicate that KYGEVVI therapy improved survival and functional outcomes in people with TK2d.1 Additional data from the largest pool of information on TK...
Royal Society of Chemistry • Jun 7, 2026

Distinct Reactivity of Aromatic and Aliphatic Thiols for the Efficient Synthesis of Chromeno[2,3-d]pyrimidine and Chromeno[4,3-b]chromene Derivatives: Mechanistic Investigations and Reaction Scope

Org. Biomol. Chem., 2026, Accepted ManuscriptDOI: 10.1039/D6OB00585C, CommunicationSuman Sourabh, Yogesh Bhaskar Singh Tanwer, Raj Rani, Sabyasachi Bhunia, S...
Plos.org • Jun 4, 2026

Mapping metabolic reprogramming in lung and breast cancer through integrative bioinformatics

Metabolic reprogramming is central to cancer biology, enabling tumor cells to sustain rapid proliferation, resist stress, and adapt to therapy. However, thes...